Diagnostic Trial of a Vision Transformer-Based Ultrasound AI Model for Placenta Accreta Spectrum
ConditionPlacenta Accreta Spectrum
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorFANG HE
About this trial
This study develops an end-to-end Vision Transformer (ViT)-based artificial intelligence system for ultrasound-based diagnosis of placenta accreta spectrum (PAS), aiming to improve the accuracy and efficiency of prenatal screening using standardized ultrasound video inputs.
Eligibility criteria
Qualifiers
Pregnant women aged between 18 and 45 years;
Gestational age between 24 and 34 weeks;
Pregnant women with a history of placenta previa;
Pregnant women with an anterior placenta;
Disqualifiers
Failure to provide written informed consent;
Presence of severe complications that precluded continuation of pregnancy;
Inability to comply with study procedures for other reasons.
Trial design
Treatments tested in this trial
- Vision Transformer-Based End-to-End Ultrasound Artificial Intelligence Model
Treatment groups
No treatment groups listed
Sponsors and collaborators
FANG HE
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Sponsor institution
Source ClinicalTrials.gov